Key facts
- This page summarizes Halley E. Gilbert's Form 4 filing for Vaxcyte, Inc. (PCVX).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 03 Jun 2021, 18:46.
Halley E. Gilbert - 02 Jun 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)
- Role
- Director
- Signature
- /s/ Ron Metzger, Attorney-in-Fact
- Issuer symbol
- PCVX
- Transactions as of
- 02 Jun 2021
- Net transaction value
- $0
- Form type
- 4
- Filing time
- 03 Jun 2021, 18:46:38 UTC
- Next filing
- 11 Jun 2021
- SEC filing
- View on sec.gov
Reporting owner
Issuer context
Transaction snapshot
SEC evidence
Key filing fact
Halley E. Gilbert filed Form 4 for Vaxcyte, Inc. (PCVX) on 03 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
PCVX
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- -15,000
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 15,000
- Date
- 02 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,000
- Exercise price
- $21.49
- Footnotes
- F1
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The shares subject to the option will vest monthly and fully vest on the earlier of June 2, 2022 or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date. |